We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
10:30 - 11:30
A3
Head & neck cancer 4
Antonio Angrisani, Switzerland;
Esther Troost, Germany
Proffered Papers
Clinical
10:30 - 11:30
Interim functional imaging response assessment as a guide for adaptive SBRT dose escalation in HNSCC; A Prospective Phase 2 clinical trial
Roa Eltagy, Egypt
-254
10:30 - 11:30
Cost-minimization of testing and therapeutic simplification for PD-1 blockade in nasopharyngeal carcinoma: A pooled analysis of three clinical trials
Cheng Xu, China
-277
10:30 - 11:30
Prospectively validated biomarker signature for personalized radiooncology: Results of the DKTK-ROG HNprädBio biomarker trial for primary RCT of HNSCC
Annett Linge, Germany
-3382
10:30 - 11:30
Sensorineural Hearing Outcomes in HPV-Positive Oropharyngeal Cancer: A Secondary Analysis of the TROG 12.01 Randomized Trial (SHOUT)
Julianne O'Shea, Australia
-3830
10:30 - 11:30
Omission of elective nodal irradiation in HNSCC: long-term results and patient-level pooled analysis from 2 prospective trials (INRT-AIR & DARTBOARD)
Sympascho Young, USA
-4291
10:30 - 11:30
Incidence and survival of supraglottic squamous cell carcinoma in Denmark, 1986–2020: a national population-based DAHANCA study of 3154 patients
Janne Minet Pedersen, Denmark
-3759